At the news
? NEUTRALIMPACT 2/10 8-K filed Jun 18, 2026 at 07:07 ET
Pfizer announced that CFO Dave Denton will step down effective August 15, 2026 to pursue a consumer goods opportunity, with Senior VP Cecile Guegan appointed as Interim CFO effective August 16. The company explicitly states the departure is unrelated to financial or operating results. A comprehensive internal and external search for a permanent CFO is underway.
- CFO Dave Denton notified Pfizer on June 16, 2026 of his departure effective August 15, 2026 for a professional opportunity outside the pharmaceutical industry in consumer goods
- Cecile Guegan, SVP Finance, Global Biopharmaceutical Business, named Interim CFO effective August 16, 2026
- Departure stated as not related to the company's financial or operating results or any disagreements with accounting/reporting policies
- Pfizer will conduct a comprehensive internal and external search for a permanent CFO successor
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access